{
    "Trade/Device Name(s)": [
        "Elecsys Calcitonin Immunoassay",
        "Elecsys Calcitonin CalSet",
        "Elecsys Calcitonin CalCheck 5",
        "Elecsys PreciControl Varia"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K132828",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023304",
        "K113546",
        "K112528",
        "K111506"
    ],
    "Regulatory Class": "Class II (Immunoassay, Calibrator); Class I (Control material)",
    "Product Code(s)": [
        "JKR",
        "JIT",
        "JJY"
    ],
    "Summary Letter Date": "December 4, 2013",
    "Summary Letter Received Date": "September 18, 2013",
    "Submission Date": "September 17, 2013",
    "Regulation Number(s)": [
        "21CFR862.1140",
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Calcitonin test system",
        "Calibrator, secondary",
        "Quality Control material"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Calcitonin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Lithium heparin tube",
        "Lithium heparin plasma gel separation tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys immunoassay analyzers",
        "cobas e immunoassay analyzers",
        "cobas e 411"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Calcitonin Immunoassay and associated calibrator and control materials for in vitro quantification of calcitonin in serum and plasma on Elecsys and cobas e analyzers.",
    "Indications for Use Summary": "In vitro quantitative determination of human calcitonin in serum and plasma to aid diagnosis and treatment of thyroid and parathyroid diseases, including carcinoma and hyperparathyroidism, in conjunction with other clinical and laboratory findings.",
    "fda_folder": "Clinical Chemistry"
}